We are delighted to be attending the HOPA 2024 conference at Tampa Florida from 3-6 April. We are looking forward to meeting you at Booth #620. March 26th 2024March 26th 2024 Read More
Shorla Oncology Announces FDA Filing Acceptance of New Drug Application for novel formulation to treat breast and ovarian cancer January 9th 2024 Read More
Press Release: Shorla Oncology Welcomes Rayna Sethi Herman as Chief Commercial Officer December 8th 2023 Read More
PRESS RELEASE: Shorla Oncology Announces US Acquisition of Jylamvo, an Oncology and Autoimmune Drug from Therakind October 31st 2023 Read More